Close Menu

NEW YORK — South Korean diagnostics firm Bioneer said on Wednesday that it has received CE-IVD marking for two combination tests for SARS-CoV-2 and influenza.

The AccuPower RV1 Real-Time RT-PCR Kit and the AccuPower RV1 Multiplex Kit are both designed to detect the E, RdRp, and N genes of SARS-CoV-2, as well as influenza A and B, in a single nasopharyngeal or oropharyngeal sample.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.